Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupGastroenterologic OncologyVisceral SurgeryDiseaseEsophageal CancerGastric CancerSubgroupAdenocarcinoma of the esophagogastric junction (AEG)ICD10C15.-C16.-C16.0MeSHEsophageal NeoplasmsStomach NeoplasmsSequenceChemotherapyChemo-substanceCisplatinChemo-substanceCisplatinChemo-substanceCisplatinChemo-substanceCisplatinNo. Substances1 RadiotherapySupportive therapySupportive substanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateSupportive substanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateSupportive substanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateSupportive substanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateNo. Substances5Protocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationTherapy phaseintraoperativTherapy intentioncurativeRisksEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorGötze TDiseaseLokalisiertes oder lokal fortgeschrittenes Magen-Ca oder Karzinom des gastroösopagealen Übergangs Typ II/IIIOriginPREVENT - FLOT9 trial of the AIO / CAOGI / ACOProtocols in Revision 1 protocol foundProtocols under revision.HIPEC - Cisplatin 75, Adenocarcinoma Esophagogastric Junction and Stomach (PID2710 V1.0)
